KRAS and non-small cell lung carcinoma: Besides, machine learning techniques in the field of MRI radiomics was applied to predict survival durations in patients with brain metastases from NSCLC, exhibiting impressive diagnostic accuracies with AUCs of more than 90% for all EGFR, ALK, and KRAS mutation-positive groups (16).